Course overview
Pharmaceutical supply chains must protect product quality, patient safety and regulatory compliance from supplier release through final delivery. Temperature excursions, falsified medicines, weak chain-of-custody records, unauthorised distribution, shortages and recall delays can lead to rejected stock, market disruption, inspection findings and patient harm. Supply chain teams need controls that preserve product identity, condition and traceability while maintaining service levels and cost discipline.
This course develops practical capability in pharmaceutical supply chain security and quality-controlled distribution. Participants examine GDP requirements, product risk classification, supplier qualification, cold-chain design, serialisation, track-and-trace data, warehouse controls, transport qualification, deviation handling, recalls and business continuity. They use risk-based methods including FMEA and ICH Q9(R1) principles to identify failure modes, rank risks and define preventive controls. The programme also addresses controlled medicines, theft prevention, third-party logistics governance and response to suspected falsified products.
Teaching combines focused instructor briefings with pharmaceutical cases, group analysis, supply disruption simulations and structured application planning. Participants progressively build a supply chain security file for a realistic pharmaceutical product, beginning with its product profile and distribution map, then adding risk assessments, control measures, temperature-management arrangements, supplier controls and incident procedures. They leave with a reusable set of templates and a reviewed supply chain security plan suitable for adaptation within their organisation.
The course suits professionals who already work with pharmaceutical procurement, quality, logistics, warehousing, distribution or supply planning and now need stronger command of product-security and GDP-controlled supply chains.